BRPI0509901A - aparelho e método para liberação transdérmica de agentes com base em fentanila - Google Patents

aparelho e método para liberação transdérmica de agentes com base em fentanila

Info

Publication number
BRPI0509901A
BRPI0509901A BRPI0509901-3A BRPI0509901A BRPI0509901A BR PI0509901 A BRPI0509901 A BR PI0509901A BR PI0509901 A BRPI0509901 A BR PI0509901A BR PI0509901 A BRPI0509901 A BR PI0509901A
Authority
BR
Brazil
Prior art keywords
fentanyl
microprojection member
based agent
based agents
contained
Prior art date
Application number
BRPI0509901-3A
Other languages
English (en)
Inventor
Mahmoud Ameri
Michel J N Cormier
Yuh-Fun Maa
Peter Daddona
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Publication of BRPI0509901A publication Critical patent/BRPI0509901A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0021—Intradermal administration, e.g. through microneedle arrays or needleless injectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A61M2037/0023—Drug applicators using microneedles

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • Medical Informatics (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

APARELHO E MéTODO PARA LIBERAçãO TRANSDéRMICA DE AGENTES COM BASE EM FENTANILA. A presente invenção refere-se a um aparelho e método para transdermicamente liberar um agente biologicamente ativo compreendendo um sistema de liberação tendo um membro de microprojeção (ou sistema) que inclui uma pluralidade de microprojeções (ou conjunto destas) que são adaptadas para perfurar através do stratum corneum na camada da epiderme subjacente, ou camadas da epiderme e da derme. Em uma modalidade, o agente com base em fentanila está contido em um revestimento biocompatível que é aplicado ao membro de microprojeção. Em uma outra modalidade, o sistema de liberação inclui um pacote de gel tendo uma formulação de hidrogel contendo agente com base em fentanila que é disposta no membro de microprojeção após aplicação à pele de um paciente. Em uma modalidade alternativa, o agente com base em fentanila está contido tanto no revestimento quanto na formulação de hidrogel.
BRPI0509901-3A 2004-04-13 2005-03-18 aparelho e método para liberação transdérmica de agentes com base em fentanila BRPI0509901A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US56194904P 2004-04-13 2004-04-13
PCT/US2005/009153 WO2005102334A2 (en) 2004-04-13 2005-03-18 Apparatus and method for transdermal delivery of fentany-based agents

Publications (1)

Publication Number Publication Date
BRPI0509901A true BRPI0509901A (pt) 2007-08-07

Family

ID=35197490

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0509901-3A BRPI0509901A (pt) 2004-04-13 2005-03-18 aparelho e método para liberação transdérmica de agentes com base em fentanila

Country Status (12)

Country Link
US (1) US20050226922A1 (pt)
EP (1) EP1737434A2 (pt)
JP (1) JP2007532645A (pt)
KR (1) KR20070011469A (pt)
CN (1) CN101027045A (pt)
AR (1) AR048827A1 (pt)
AU (1) AU2005235075A1 (pt)
BR (1) BRPI0509901A (pt)
CA (1) CA2562731A1 (pt)
MX (1) MXPA06011972A (pt)
TW (1) TW200602099A (pt)
WO (1) WO2005102334A2 (pt)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2014202738B2 (en) * 2005-06-17 2016-05-12 Wisconsin Alumni Research Foundation Topical vasoconstrictor preparations and methods for protecting cells during cancer chemotherapy and radiotherapy
AU2012202731B2 (en) * 2005-06-17 2014-06-19 Wisconsin Alumni Research Foundation Topical vasoconstrictor preparations and methods for protecting cells during cancer chemotherapy and radiotherapy
PL1890732T3 (pl) 2005-06-17 2018-11-30 Wisconsin Alumni Research Foundation Preparaty zwężające naczynia krwionośne do podawania miejscowego i sposoby ochrony komórek podczas chemioterapii i radioterapii przeciwnowotworowej
CN101330824A (zh) * 2005-12-14 2008-12-24 阿里亚纳控股有限公司 化学制品施用器
US20070299388A1 (en) * 2006-04-25 2007-12-27 Alza Corporation Microprojection array application with multilayered microprojection member for high drug loading
US20070293816A1 (en) * 2006-04-25 2007-12-20 Alza Corporation Microprojection Array Application with Grouped Microprojections for High Drug Loading
US10512644B2 (en) 2007-03-12 2019-12-24 Inheris Pharmaceuticals, Inc. Oligomer-opioid agonist conjugates
US8173666B2 (en) 2007-03-12 2012-05-08 Nektar Therapeutics Oligomer-opioid agonist conjugates
HUP0700828A2 (en) * 2007-12-20 2010-01-28 Richter Gedeon Nyrt Transdermal pharmaceutical compositions containing tolperisone alone and in combination
CA2734333A1 (en) * 2008-09-16 2010-03-25 Nektar Therapeutics Pegylated opioids with low potential for abuse
US8888761B2 (en) * 2009-11-13 2014-11-18 The Invention Science Fund I, Llc Device, system, and method for targeted delivery of anti-inflammatory medicaments to a mammalian subject
US8894630B2 (en) 2009-11-13 2014-11-25 The Invention Science Fund I, Llc Device, system, and method for targeted delivery of anti-inflammatory medicaments to a mammalian subject
US8439896B2 (en) * 2009-11-13 2013-05-14 The Invention Science Fund I, Llc Device, system, and method for targeted delivery of anti-inflammatory medicaments to a mammalian subject
US20120295279A1 (en) * 2010-02-05 2012-11-22 Nichirei Biosciences Inc. Pretreatment solution for immunohistochemical staining and condensed solution thereof
CN105815785A (zh) * 2016-03-31 2016-08-03 常州大学 一种从黄瓜中提取丙醇二酸制备除脂粉的方法
US9650338B1 (en) 2016-07-29 2017-05-16 VDM Biochemicals, Inc. Opioid antagonist compounds and methods of making and using
EP4684865A3 (en) 2017-04-18 2026-03-18 Nouvel Technologies Inc. Sulfur production
EP3723725B1 (de) * 2017-12-14 2022-02-02 LTS LOHMANN Therapie-Systeme AG Mikronadelarray aufweisend einen wirkstoff in form von salzen
CN108318646A (zh) * 2018-03-27 2018-07-24 苏州桓晨医疗科技有限公司 一种模拟药物体外释放的释放介质
CA3176328A1 (en) * 2020-04-22 2021-10-28 Mahmoud Ameri Transdermal active agent delivery devices having coronavirus vaccine coated microprotrusions

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3964482A (en) * 1971-05-17 1976-06-22 Alza Corporation Drug delivery device
BE795384A (fr) * 1972-02-14 1973-08-13 Ici Ltd Pansements
US4486423A (en) * 1983-04-21 1984-12-04 Janssen Pharmaceutica Inc. Stable fentanyl composition
US5080646A (en) * 1988-10-03 1992-01-14 Alza Corporation Membrane for electrotransport transdermal drug delivery
US5169382A (en) * 1988-10-03 1992-12-08 Alza Corporation Membrane for electrotransport transdermal drug delivery
US5147296A (en) * 1988-10-03 1992-09-15 Alza Corporation Membrane for electrotransport transdermal drug delivery
US5378475A (en) * 1991-02-21 1995-01-03 University Of Kentucky Research Foundation Sustained release drug delivery devices
US5916596A (en) * 1993-02-22 1999-06-29 Vivorx Pharmaceuticals, Inc. Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
AU5740496A (en) * 1995-05-22 1996-12-11 General Hospital Corporation, The Micromechanical device and method for enhancing delivery of compounds through the skin
US6143037A (en) * 1996-06-12 2000-11-07 The Regents Of The University Of Michigan Compositions and methods for coating medical devices
US5738728A (en) * 1996-07-26 1998-04-14 Bio Dot, Inc. Precision metered aerosol dispensing apparatus
US5741554A (en) * 1996-07-26 1998-04-21 Bio Dot, Inc. Method of dispensing a liquid reagent
US5743960A (en) * 1996-07-26 1998-04-28 Bio-Dot, Inc. Precision metered solenoid valve dispenser
US5916524A (en) * 1997-07-23 1999-06-29 Bio-Dot, Inc. Dispensing apparatus having improved dynamic range
EP1037686B1 (en) * 1997-12-11 2005-08-17 Alza Corporation Device for enhancing transdermal agent flux
AU739616B2 (en) * 1997-12-11 2001-10-18 Alza Corporation Device for enhancing transdermal agent flux
US6091975A (en) * 1998-04-01 2000-07-18 Alza Corporation Minimally invasive detecting device
JP4205778B2 (ja) * 1998-04-17 2009-01-07 久光製薬株式会社 貼付製剤
KR100622332B1 (ko) * 1999-04-01 2006-09-13 알자 코포레이션 폴리우레탄 약물 리저버를 함유하는 경피 약물 수송 장치
US6250023B1 (en) * 1999-10-19 2001-06-26 Bruce A. Donoho Preventive device against nuisance from birds
WO2001064149A1 (en) * 2000-02-29 2001-09-07 Jie Zhang Improved transdermal drug patch
BR0113749A (pt) * 2000-09-08 2004-06-22 Alza Corp Métodos para inibir a diminuição no fluxo de droga transdérmica por inibição do fechamento das vias
US20020119187A1 (en) * 2000-09-29 2002-08-29 Cantor Adam S. Composition for the transdermal delivery of fentanyl
IL155389A0 (en) * 2000-10-13 2003-11-23 Alza Corportion Microprotrusion member retainer for impact applicator
WO2002074173A1 (en) * 2001-03-16 2002-09-26 Alza Corporation Method and apparatus for coating skin piercing microprojections
WO2002085447A2 (en) * 2001-04-20 2002-10-31 Alza Corporation Microprojection array having a beneficial agent containing coating
DE10141650C1 (de) * 2001-08-24 2002-11-28 Lohmann Therapie Syst Lts Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen
JP4790219B2 (ja) * 2002-03-26 2011-10-12 ユーロ−セルティーク エス．エイ． 徐放性ゲルコーティング組成物

Also Published As

Publication number Publication date
AU2005235075A1 (en) 2005-11-03
MXPA06011972A (es) 2007-04-16
EP1737434A2 (en) 2007-01-03
TW200602099A (en) 2006-01-16
JP2007532645A (ja) 2007-11-15
KR20070011469A (ko) 2007-01-24
CN101027045A (zh) 2007-08-29
CA2562731A1 (en) 2005-11-03
WO2005102334A3 (en) 2006-02-09
AR048827A1 (es) 2006-05-31
US20050226922A1 (en) 2005-10-13
WO2005102334A2 (en) 2005-11-03

Similar Documents

Publication Publication Date Title
BRPI0417757A (pt) método e sistema de liberação de agente transdérmico assistida por freqüência
BRPI0416822A (pt) método e sistema de liberação de vacina transdérmica com ultra-som
BRPI0509901A (pt) aparelho e método para liberação transdérmica de agentes com base em fentanila
BRPI0509788A (pt) aparato e método para liberação transdérmica de agentes de hormÈnio paratireóides
BRPI0509493A (pt) aparelho e método para a liberação transdérmica de vacina da influenza
BRPI0415466A (pt) método e sistema de pré-tratamento para intensificar a distribuição transdérmica de fármacos
Ronnander et al. Dissolving polyvinylpyrrolidone-based microneedle systems for in-vitro delivery of sumatriptan succinate
TW200618830A (en) Micorprojection apparatus and system with low infection potential
BRPI0415967A (pt) aplicação de conjugados de polìmero de peptìdeos e proteìnas terapêuticos através de microprojeções revestidas
WO2007106597A3 (en) Method for the transdermal delivery of parathyroid hormone agents for treating osteopenia
BR0317743A (pt) Dispositivo de liberação de agente ativo tendo membros de compósito
BR0209046A (pt) Disposição de microprojeção que possui um agente benéfico contendo revestimento
BRPI0517501A (pt) dispositivo médico apropriado para uso na administração de um componente ativo na ou através da pele
BR0312671A (pt) Dispositivo de microagulhas, método para utilizar um dispositivo de microagulhas, e, método para aplicar um dispositivo de microagulhas
Ghaferi et al. Transdermal Drug Delivery Systems (TDDS): recent advances and failure modes
BRPI0415986A (pt) método e aparelho para reduzir a incidência do uso de tabaco
BRPI0511235A (pt) preparado tópico e método para a administração transdérmica e localização de agentes terapêuticos
JP2003525641A (ja) 爪真菌症の治療用感圧接着性マトリックス・パッチ
BRPI0417437A (pt) dispositivo para inibição da absorção, dispositivo para remoção de agente fisiologicamente ativo e dispositivo para redução do efeito de overdose
TW200616660A (en) Apparatus and method for transdermal delivery of natriuretic peptides
BR0316463A (pt) Administração dérmica de um inibidor seletivo de ciclooxigenase-2 solúvel em água, por exemplo, derivados de parecoxib, valdecoxib e benzopirano
TW200738252A (en) Apparatus and method for transdermal delivery of Epoetin-based agents
BR0316436A (pt) Emplastro inibidor seletivo de ciclooxigenase-2
TW200621316A (en) Apparatus and method for transdermal delivery of vascular endothelial growth factors
TH86804A (th) เครื่องมือ และวิธีการสำหรับการนำส่งผ่านผิวหนังของตัวกระทำที่มีอีโพอีทินเป็นพื้นฐาน

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]